Global H1N1 Vaccines Market Research Report 2023

Global H1N1 Vaccines Market Research Report 2023

Table of Contents
1 H1N1 Vaccines Market Overview
1.1 Product Overview and Scope of H1N1 Vaccines
1.2 H1N1 Vaccines Segment by Type
1.2.1 Global H1N1 Vaccines Market Value Comparison by Type (2023-2029)
1.2.2 Intramuscular Vaccines
1.2.3 Intranasal Vaccines
1.2.4 Intradermal Vaccines
1.3 H1N1 Vaccines Segment by Application
1.3.1 Global H1N1 Vaccines Market Value by Application: (2023-2029)
1.3.2 Influenza
1.3.3 Meningococcal
1.3.4 Cervical Cancer
1.3.5 Pneumococcal
1.3.6 Hepatitis
1.3.7 Measles
1.3.8 Mumps
1.3.9 Rubella
1.3.10 Others
1.4 Global H1N1 Vaccines Market Size Estimates and Forecasts
1.4.1 Global H1N1 Vaccines Revenue 2018-2029
1.4.2 Global H1N1 Vaccines Sales 2018-2029
1.4.3 Global H1N1 Vaccines Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 H1N1 Vaccines Market Competition by Manufacturers
2.1 Global H1N1 Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global H1N1 Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global H1N1 Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global H1N1 Vaccines Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of H1N1 Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of H1N1 Vaccines, Product Type & Application
2.7 H1N1 Vaccines Market Competitive Situation and Trends
2.7.1 H1N1 Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest H1N1 Vaccines Players Market Share by Revenue
2.7.3 Global H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 H1N1 Vaccines Retrospective Market Scenario by Region
3.1 Global H1N1 Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global H1N1 Vaccines Global H1N1 Vaccines Sales by Region: 2018-2029
3.2.1 Global H1N1 Vaccines Sales by Region: 2018-2023
3.2.2 Global H1N1 Vaccines Sales by Region: 2024-2029
3.3 Global H1N1 Vaccines Global H1N1 Vaccines Revenue by Region: 2018-2029
3.3.1 Global H1N1 Vaccines Revenue by Region: 2018-2023
3.3.2 Global H1N1 Vaccines Revenue by Region: 2024-2029
3.4 North America H1N1 Vaccines Market Facts & Figures by Country
3.4.1 North America H1N1 Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America H1N1 Vaccines Sales by Country (2018-2029)
3.4.3 North America H1N1 Vaccines Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe H1N1 Vaccines Market Facts & Figures by Country
3.5.1 Europe H1N1 Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe H1N1 Vaccines Sales by Country (2018-2029)
3.5.3 Europe H1N1 Vaccines Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific H1N1 Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific H1N1 Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific H1N1 Vaccines Sales by Country (2018-2029)
3.6.3 Asia Pacific H1N1 Vaccines Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America H1N1 Vaccines Market Facts & Figures by Country
3.7.1 Latin America H1N1 Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America H1N1 Vaccines Sales by Country (2018-2029)
3.7.3 Latin America H1N1 Vaccines Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa H1N1 Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa H1N1 Vaccines Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa H1N1 Vaccines Sales by Country (2018-2029)
3.8.3 Middle East and Africa H1N1 Vaccines Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global H1N1 Vaccines Sales by Type (2018-2029)
4.1.1 Global H1N1 Vaccines Sales by Type (2018-2023)
4.1.2 Global H1N1 Vaccines Sales by Type (2024-2029)
4.1.3 Global H1N1 Vaccines Sales Market Share by Type (2018-2029)
4.2 Global H1N1 Vaccines Revenue by Type (2018-2029)
4.2.1 Global H1N1 Vaccines Revenue by Type (2018-2023)
4.2.2 Global H1N1 Vaccines Revenue by Type (2024-2029)
4.2.3 Global H1N1 Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global H1N1 Vaccines Price by Type (2018-2029)
5 Segment by Application
5.1 Global H1N1 Vaccines Sales by Application (2018-2029)
5.1.1 Global H1N1 Vaccines Sales by Application (2018-2023)
5.1.2 Global H1N1 Vaccines Sales by Application (2024-2029)
5.1.3 Global H1N1 Vaccines Sales Market Share by Application (2018-2029)
5.2 Global H1N1 Vaccines Revenue by Application (2018-2029)
5.2.1 Global H1N1 Vaccines Revenue by Application (2018-2023)
5.2.2 Global H1N1 Vaccines Revenue by Application (2024-2029)
5.2.3 Global H1N1 Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global H1N1 Vaccines Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott H1N1 Vaccines Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Baxter International
6.2.1 Baxter International Corporation Information
6.2.2 Baxter International Description and Business Overview
6.2.3 Baxter International H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Baxter International H1N1 Vaccines Product Portfolio
6.2.5 Baxter International Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi H1N1 Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK H1N1 Vaccines Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Pfizer H1N1 Vaccines Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Mitsubishi Tanabe Pharma
6.6.1 Mitsubishi Tanabe Pharma Corporation Information
6.6.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.6.3 Mitsubishi Tanabe Pharma H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Mitsubishi Tanabe Pharma H1N1 Vaccines Product Portfolio
6.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.7 Hualan Biological Engineering
6.6.1 Hualan Biological Engineering Corporation Information
6.6.2 Hualan Biological Engineering Description and Business Overview
6.6.3 Hualan Biological Engineering H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hualan Biological Engineering H1N1 Vaccines Product Portfolio
6.7.5 Hualan Biological Engineering Recent Developments/Updates
6.8 Cipla
6.8.1 Cipla Corporation Information
6.8.2 Cipla Description and Business Overview
6.8.3 Cipla H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cipla H1N1 Vaccines Product Portfolio
6.8.5 Cipla Recent Developments/Updates
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Merck H1N1 Vaccines Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Sinovac Biotech
6.10.1 Sinovac Biotech Corporation Information
6.10.2 Sinovac Biotech Description and Business Overview
6.10.3 Sinovac Biotech H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sinovac Biotech H1N1 Vaccines Product Portfolio
6.10.5 Sinovac Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 H1N1 Vaccines Industry Chain Analysis
7.2 H1N1 Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 H1N1 Vaccines Production Mode & Process
7.4 H1N1 Vaccines Sales and Marketing
7.4.1 H1N1 Vaccines Sales Channels
7.4.2 H1N1 Vaccines Distributors
7.5 H1N1 Vaccines Customers
8 H1N1 Vaccines Market Dynamics
8.1 H1N1 Vaccines Industry Trends
8.2 H1N1 Vaccines Market Drivers
8.3 H1N1 Vaccines Market Challenges
8.4 H1N1 Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global H1N1 Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global H1N1 Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global H1N1 Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global H1N1 Vaccines Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global H1N1 Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 6. Global H1N1 Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global H1N1 Vaccines Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market H1N1 Vaccines Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of H1N1 Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of H1N1 Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of H1N1 Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of H1N1 Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global H1N1 Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in H1N1 Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global H1N1 Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global H1N1 Vaccines Sales by Region (2018-2023) & (K Units)
Table 18. Global H1N1 Vaccines Sales Market Share by Region (2018-2023)
Table 19. Global H1N1 Vaccines Sales by Region (2024-2029) & (K Units)
Table 20. Global H1N1 Vaccines Sales Market Share by Region (2024-2029)
Table 21. Global H1N1 Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global H1N1 Vaccines Revenue Market Share by Region (2018-2023)
Table 23. Global H1N1 Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global H1N1 Vaccines Revenue Market Share by Region (2024-2029)
Table 25. North America H1N1 Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America H1N1 Vaccines Sales by Country (2018-2023) & (K Units)
Table 27. North America H1N1 Vaccines Sales by Country (2024-2029) & (K Units)
Table 28. North America H1N1 Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America H1N1 Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe H1N1 Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe H1N1 Vaccines Sales by Country (2018-2023) & (K Units)
Table 32. Europe H1N1 Vaccines Sales by Country (2024-2029) & (K Units)
Table 33. Europe H1N1 Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe H1N1 Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific H1N1 Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific H1N1 Vaccines Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific H1N1 Vaccines Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific H1N1 Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific H1N1 Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America H1N1 Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America H1N1 Vaccines Sales by Country (2018-2023) & (K Units)
Table 42. Latin America H1N1 Vaccines Sales by Country (2024-2029) & (K Units)
Table 43. Latin America H1N1 Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America H1N1 Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa H1N1 Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa H1N1 Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa H1N1 Vaccines Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa H1N1 Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa H1N1 Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global H1N1 Vaccines Sales (K Units) by Type (2018-2023)
Table 51. Global H1N1 Vaccines Sales (K Units) by Type (2024-2029)
Table 52. Global H1N1 Vaccines Sales Market Share by Type (2018-2023)
Table 53. Global H1N1 Vaccines Sales Market Share by Type (2024-2029)
Table 54. Global H1N1 Vaccines Revenue (US$ Million) by Type (2018-2023)
Table 55. Global H1N1 Vaccines Revenue (US$ Million) by Type (2024-2029)
Table 56. Global H1N1 Vaccines Revenue Market Share by Type (2018-2023)
Table 57. Global H1N1 Vaccines Revenue Market Share by Type (2024-2029)
Table 58. Global H1N1 Vaccines Price (USD/Unit) by Type (2018-2023)
Table 59. Global H1N1 Vaccines Price (USD/Unit) by Type (2024-2029)
Table 60. Global H1N1 Vaccines Sales (K Units) by Application (2018-2023)
Table 61. Global H1N1 Vaccines Sales (K Units) by Application (2024-2029)
Table 62. Global H1N1 Vaccines Sales Market Share by Application (2018-2023)
Table 63. Global H1N1 Vaccines Sales Market Share by Application (2024-2029)
Table 64. Global H1N1 Vaccines Revenue (US$ Million) by Application (2018-2023)
Table 65. Global H1N1 Vaccines Revenue (US$ Million) by Application (2024-2029)
Table 66. Global H1N1 Vaccines Revenue Market Share by Application (2018-2023)
Table 67. Global H1N1 Vaccines Revenue Market Share by Application (2024-2029)
Table 68. Global H1N1 Vaccines Price (USD/Unit) by Application (2018-2023)
Table 69. Global H1N1 Vaccines Price (USD/Unit) by Application (2024-2029)
Table 70. Abbott Corporation Information
Table 71. Abbott Description and Business Overview
Table 72. Abbott H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Abbott H1N1 Vaccines Product
Table 74. Abbott Recent Developments/Updates
Table 75. Baxter International Corporation Information
Table 76. Baxter International Description and Business Overview
Table 77. Baxter International H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Baxter International H1N1 Vaccines Product
Table 79. Baxter International Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Sanofi H1N1 Vaccines Product
Table 84. Sanofi Recent Developments/Updates
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. GSK H1N1 Vaccines Product
Table 89. GSK Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Pfizer H1N1 Vaccines Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Mitsubishi Tanabe Pharma Corporation Information
Table 96. Mitsubishi Tanabe Pharma Description and Business Overview
Table 97. Mitsubishi Tanabe Pharma H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Mitsubishi Tanabe Pharma H1N1 Vaccines Product
Table 99. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 100. Hualan Biological Engineering Corporation Information
Table 101. Hualan Biological Engineering Description and Business Overview
Table 102. Hualan Biological Engineering H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Hualan Biological Engineering H1N1 Vaccines Product
Table 104. Hualan Biological Engineering Recent Developments/Updates
Table 105. Cipla Corporation Information
Table 106. Cipla Description and Business Overview
Table 107. Cipla H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Cipla H1N1 Vaccines Product
Table 109. Cipla Recent Developments/Updates
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Merck H1N1 Vaccines Product
Table 114. Merck Recent Developments/Updates
Table 115. Sinovac Biotech Corporation Information
Table 116. Sinovac Biotech Description and Business Overview
Table 117. Sinovac Biotech H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Sinovac Biotech H1N1 Vaccines Product
Table 119. Sinovac Biotech Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. H1N1 Vaccines Distributors List
Table 123. H1N1 Vaccines Customers List
Table 124. H1N1 Vaccines Market Trends
Table 125. H1N1 Vaccines Market Drivers
Table 126. H1N1 Vaccines Market Challenges
Table 127. H1N1 Vaccines Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of H1N1 Vaccines
Figure 2. Global H1N1 Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global H1N1 Vaccines Market Share by Type in 2022 & 2029
Figure 4. Intramuscular Vaccines Product Picture
Figure 5. Intranasal Vaccines Product Picture
Figure 6. Intradermal Vaccines Product Picture
Figure 7. Global H1N1 Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global H1N1 Vaccines Market Share by Application in 2022 & 2029
Figure 9. Influenza
Figure 10. Meningococcal
Figure 11. Cervical Cancer
Figure 12. Pneumococcal
Figure 13. Hepatitis
Figure 14. Measles
Figure 15. Mumps
Figure 16. Rubella
Figure 17. Others
Figure 18. Global H1N1 Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global H1N1 Vaccines Market Size (2018-2029) & (US$ Million)
Figure 20. Global H1N1 Vaccines Sales (2018-2029) & (K Units)
Figure 21. Global H1N1 Vaccines Average Price (USD/Unit) & (2018-2029)
Figure 22. H1N1 Vaccines Report Years Considered
Figure 23. H1N1 Vaccines Sales Share by Manufacturers in 2022
Figure 24. Global H1N1 Vaccines Revenue Share by Manufacturers in 2022
Figure 25. The Global 5 and 10 Largest H1N1 Vaccines Players: Market Share by Revenue in 2022
Figure 26. H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 27. Global H1N1 Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 28. North America H1N1 Vaccines Sales Market Share by Country (2018-2029)
Figure 29. North America H1N1 Vaccines Revenue Market Share by Country (2018-2029)
Figure 30. U.S. H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Canada H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Europe H1N1 Vaccines Sales Market Share by Country (2018-2029)
Figure 33. Europe H1N1 Vaccines Revenue Market Share by Country (2018-2029)
Figure 34. Germany H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. France H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. U.K. H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Italy H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Russia H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Asia Pacific H1N1 Vaccines Sales Market Share by Region (2018-2029)
Figure 40. Asia Pacific H1N1 Vaccines Revenue Market Share by Region (2018-2029)
Figure 41. China H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Japan H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. South Korea H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. India H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Australia H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Taiwan H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Indonesia H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Thailand H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Malaysia H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Philippines H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Latin America H1N1 Vaccines Sales Market Share by Country (2018-2029)
Figure 52. Latin America H1N1 Vaccines Revenue Market Share by Country (2018-2029)
Figure 53. Mexico H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Brazil H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Argentina H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Middle East & Africa H1N1 Vaccines Sales Market Share by Country (2018-2029)
Figure 57. Middle East & Africa H1N1 Vaccines Revenue Market Share by Country (2018-2029)
Figure 58. Turkey H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. U.A.E H1N1 Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Global Sales Market Share of H1N1 Vaccines by Type (2018-2029)
Figure 62. Global Revenue Market Share of H1N1 Vaccines by Type (2018-2029)
Figure 63. Global H1N1 Vaccines Price (USD/Unit) by Type (2018-2029)
Figure 64. Global Sales Market Share of H1N1 Vaccines by Application (2018-2029)
Figure 65. Global Revenue Market Share of H1N1 Vaccines by Application (2018-2029)
Figure 66. Global H1N1 Vaccines Price (USD/Unit) by Application (2018-2029)
Figure 67. H1N1 Vaccines Value Chain
Figure 68. H1N1 Vaccines Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Distributors Profiles
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global H1N1 Vaccines Market Insights, Forecast to 2029

Published: 30-May-2023        Price: US 4900 Onwards        Pages: 110

A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The global H1N1 Vaccines market is projected to grow from US$ 4739.1 million in 2023 to US$ 5708.3 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period. The global H1N1 vaccination market is anticipated to boost in the focus perio......

Global Avian Influenza Vaccines Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 11-May-2023        Price: US 3260 Onwards        Pages: 111

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred. The Avian Influenza Vaccines market revenue was 933.69 Million USD in 2022, and will reach 1586.45 Million USD in 2028, with a CAGR......

Global Meningococcal Vaccines Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 25-Apr-2023        Price: US 3260 Onwards        Pages: 95

The Meningococcal Vaccines market revenue was 4612.21 Million USD in 2022, and will reach 10398.15 Million USD in 2028, with a CAGR of 14.51% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Meningococcal Vaccines industry, and breaks down according to the type, application, and consumption area of Meningococcal Vaccines. The report also introduces players in the industry from the perspective of the industry chain and marke......

Global Meningococcal Conjugate Market Research Report 2023

Published: 11-Apr-2023        Price: US 2900 Onwards        Pages: 93

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease. Highlights The global Meningococcal Conjugate market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during t......

Global Influenza Vaccine Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 11-Apr-2023        Price: US 3260 Onwards        Pages: 112

Influenza Vaccine are vaccines that protect against infection by influenza viruses. The Influenza Vaccine market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Influenza Vaccine industry, and breaks down according to the type, application, and consumption area of Influenza Vaccine. The report also introduces players in the......

2023-2031 Report on Global Encephalitis Vaccination Market by Player, Region, Type, Application and Sales Channel

Published: 13-Mar-2023        Price: US 2500 Onwards        Pages: 92

This report studies the Encephalitis Vaccination market, covering market size for segment by type (Encephalitis B Vaccine, Encephalitis Attenuated Live Vaccine, etc.), by application (Hospitals, Other Medical Institutions, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Novartis, Sanofi, Chengdu institute of biologica, Wuhan Institute of Biological, Lanzhou Institute of Biological, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East ......

2023-2031 Report on Global Avian Influenza Vaccines Market by Player, Region, Type, Application and Sales Channel

Published: 13-Mar-2023        Price: US 2500 Onwards        Pages: 87

This report studies the Avian Influenza Vaccines market, covering market size for segment by type (Type H5, Type H9, etc.), by application (Chicken, Duck & Goose, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merial, CEVA, Zoetis, Elanco (Lohmann), Merck Animal Health, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Avian Influenza ......

Global H1N1 Vaccines Market Research Report 2023

Published: 07-Mar-2023        Price: US 2900 Onwards        Pages: 90

A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. Highlights The global H1N1 Vaccines market was valued at US$ 4576.4 million in 2022 and is anticipated to reach US$ 5708.3 million by 2029, witnessing a CAGR of 3.2% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were co......

Global Pneumococcal Polysaccharide Vaccine Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 02-Mar-2023        Price: US 3260 Onwards        Pages: 95

The Pneumococcal Polysaccharide Vaccine market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Pneumococcal Polysaccharide Vaccine industry, and breaks down according to the type, application, and consumption area of Pneumococcal Polysaccharide Vaccine. The report also introduces players in the industry from the perspective of the......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs